973 related articles for article (PubMed ID: 30307737)
21. Eicosapentaenoic Acid for Cardiovascular Events Reduction- Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Yokoyama Y; Kuno T; Morita SX; Slipczuk L; Takagi H; Briasoulis A; Latib A; Bangalore S; Heffron SP
J Cardiol; 2022 Nov; 80(5):416-422. PubMed ID: 35914996
[TBL] [Abstract][Full Text] [Related]
22. N-3 fatty acid supplementation mediates lipid profile, including small dense LDL, when combined with statins: a randomized double blind placebo controlled trial.
Dogay Us G; Mushtaq S
Lipids Health Dis; 2022 Sep; 21(1):84. PubMed ID: 36050695
[TBL] [Abstract][Full Text] [Related]
23. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
[TBL] [Abstract][Full Text] [Related]
24. Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trials.
Massara P; Zurbau A; Glenn AJ; Chiavaroli L; Khan TA; Viguiliouk E; Mejia SB; Comelli EM; Chen V; Schwab U; Risérus U; Uusitupa M; Aas AM; Hermansen K; Thorsdottir I; Rahelić D; Kahleová H; Salas-Salvadó J; Kendall CWC; Sievenpiper JL
Diabetologia; 2022 Dec; 65(12):2011-2031. PubMed ID: 36008559
[TBL] [Abstract][Full Text] [Related]
25. Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial.
Myhre PL; Kalstad AA; Tveit SH; Laake K; Schmidt EB; Smith P; Nilsen DWT; Tveit A; Solheim S; Arnesen H; Seljeflot I
J Intern Med; 2022 May; 291(5):637-647. PubMed ID: 34982486
[TBL] [Abstract][Full Text] [Related]
26. TRIGLYCERIDES, ATHEROSCLEROSIS, AND CARDIOVASCULAR OUTCOME STUDIES: FOCUS ON OMEGA-3 FATTY ACIDS.
Handelsman Y; Shapiro MD
Endocr Pract; 2017 Jan; 23(1):100-112. PubMed ID: 27819772
[TBL] [Abstract][Full Text] [Related]
27. Diets enriched in menhaden fish oil, seal oil, or shark liver oil have distinct effects on the lipid and fatty-acid composition of guinea pig heart.
Murphy MG; Wright V; Ackman RG; Horackova M
Mol Cell Biochem; 1997 Dec; 177(1-2):257-69. PubMed ID: 9450671
[TBL] [Abstract][Full Text] [Related]
28. ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies.
Del Gobbo LC; Imamura F; Aslibekyan S; Marklund M; Virtanen JK; Wennberg M; Yakoob MY; Chiuve SE; Dela Cruz L; Frazier-Wood AC; Fretts AM; Guallar E; Matsumoto C; Prem K; Tanaka T; Wu JH; Zhou X; Helmer C; Ingelsson E; Yuan JM; Barberger-Gateau P; Campos H; Chaves PH; Djoussé L; Giles GG; Gómez-Aracena J; Hodge AM; Hu FB; Jansson JH; Johansson I; Khaw KT; Koh WP; Lemaitre RN; Lind L; Luben RN; Rimm EB; Risérus U; Samieri C; Franks PW; Siscovick DS; Stampfer M; Steffen LM; Steffen BT; Tsai MY; van Dam RM; Voutilainen S; Willett WC; Woodward M; Mozaffarian D;
JAMA Intern Med; 2016 Aug; 176(8):1155-66. PubMed ID: 27357102
[TBL] [Abstract][Full Text] [Related]
29. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
Nicholls SJ; Lincoff AM; Garcia M; Bash D; Ballantyne CM; Barter PJ; Davidson MH; Kastelein JJP; Koenig W; McGuire DK; Mozaffarian D; Ridker PM; Ray KK; Katona BG; Himmelmann A; Loss LE; Rensfeldt M; Lundström T; Agrawal R; Menon V; Wolski K; Nissen SE
JAMA; 2020 Dec; 324(22):2268-2280. PubMed ID: 33190147
[TBL] [Abstract][Full Text] [Related]
30. Reduction in saturated fat intake for cardiovascular disease.
Hooper L; Martin N; Jimoh OF; Kirk C; Foster E; Abdelhamid AS
Cochrane Database Syst Rev; 2020 May; 5(5):CD011737. PubMed ID: 32428300
[TBL] [Abstract][Full Text] [Related]
31. A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk.
Alexander DD; Miller PE; Van Elswyk ME; Kuratko CN; Bylsma LC
Mayo Clin Proc; 2017 Jan; 92(1):15-29. PubMed ID: 28062061
[TBL] [Abstract][Full Text] [Related]
32. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
Hu Y; Hu FB; Manson JE
J Am Heart Assoc; 2019 Oct; 8(19):e013543. PubMed ID: 31567003
[TBL] [Abstract][Full Text] [Related]
33. Marine-derived n-3 fatty acids therapy for stroke.
Alvarez Campano CG; Macleod MJ; Aucott L; Thies F
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012815. PubMed ID: 31242320
[TBL] [Abstract][Full Text] [Related]
34. Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial.
Asztalos IB; Gleason JA; Sever S; Gedik R; Asztalos BF; Horvath KV; Dansinger ML; Lamon-Fava S; Schaefer EJ
Metabolism; 2016 Nov; 65(11):1636-1645. PubMed ID: 27733252
[TBL] [Abstract][Full Text] [Related]
35. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
36. Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review.
Jacobson TA; Glickstein SB; Rowe JD; Soni PN
J Clin Lipidol; 2012; 6(1):5-18. PubMed ID: 22264569
[TBL] [Abstract][Full Text] [Related]
37. Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.
Schmucker C; Eisele-Metzger A; Meerpohl JJ; Lehane C; Kuellenberg de Gaudry D; Lohner S; Schwingshackl L
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013556. PubMed ID: 35199850
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]